Table 4. Plasma Ngal levels in patients with and without each component of metabolic syndrome.
Plasma Ngal levels (ng/ml) | |||
Comorbidity(+) | Comorbidity(−) | p | |
Hypertension | 52.7±1.7 | 48.0±2.1 | 0.17 |
(n = 61) | (n = 41) | ||
Hyperglycemia | 48.4±14.5 | 51.4±13.0 | 0.27 |
(n = 21) | (n = 81) | ||
Dyslipidemia | 51.9±14.7 | 49.9±12.2 | 0.49 |
(n = 46) | (n = 56) | ||
Visceral fat accumulation | 50.9±14.1 | 50.5±11.6 | 0.92 |
(n = 70) | (n = 32) | ||
Metabolic syndrome | 51.8±16.7 | 50.2±11.1 | 0.93 |
(n = 37) | (n = 65) |
Data are expressed in mean ± SD.
Ngal: neutrophil gelatinase associated lipocalin.